Brief: vTv Therapeutics Receives Notice Of Delisting From Nasdaq
23/12/2022 21:40
Dec 23 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS - ON DEC 22 CO RECEIVED NOTICE OF
DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Source: (https://bit.ly/3WI7wjK)
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)